The global Percutaneous Prosthetic Heart Valve System market size is predicted to grow from US$ 7294 million in 2025 to US$ 13202 million in 2031; it is expected to grow at a CAGR of 10.4% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A percutaneous prosthetic heart valve system is a minimally invasive medical device designed to replace a diseased heart valve—most commonly the aortic valve—via catheter-based delivery without the need for open-heart surgery. This system typically includes a collapsible bioprosthetic valve mounted on a stent, a catheter delivery system, and guiding tools for precise placement. It is primarily used in transcatheter aortic valve replacement (TAVR) procedures, especially in patients at high or intermediate surgical risk.
United States market for Percutaneous Prosthetic Heart Valve System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Percutaneous Prosthetic Heart Valve System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Percutaneous Prosthetic Heart Valve System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Percutaneous Prosthetic Heart Valve System players cover Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, MicroPort, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The “Percutaneous Prosthetic Heart Valve System Industry Forecast” looks at past sales and reviews total world Percutaneous Prosthetic Heart Valve System sales in 2024, providing a comprehensive analysis by region and market sector of projected Percutaneous Prosthetic Heart Valve System sales for 2025 through 2031. With Percutaneous Prosthetic Heart Valve System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Percutaneous Prosthetic Heart Valve System industry.
This Insight Report provides a comprehensive analysis of the global Percutaneous Prosthetic Heart Valve System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Percutaneous Prosthetic Heart Valve System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Percutaneous Prosthetic Heart Valve System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Percutaneous Prosthetic Heart Valve System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Percutaneous Prosthetic Heart Valve System.
This report presents a comprehensive overview, market shares, and growth opportunities of Percutaneous Prosthetic Heart Valve System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Balloon-expandable
Self-expanding
Other
Segmentation by Application:
Hospital
Cardiac Catheterization Laboratory
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Edwards Lifesciences
Medtronic
Boston Scientific
Abbott
MicroPort
Venus Medtech
Jenscare Biotechnology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Percutaneous Prosthetic Heart Valve System market?
What factors are driving Percutaneous Prosthetic Heart Valve System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Percutaneous Prosthetic Heart Valve System market opportunities vary by end market size?
How does Percutaneous Prosthetic Heart Valve System break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Percutaneous Prosthetic Heart Valve System Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Percutaneous Prosthetic Heart Valve System by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Percutaneous Prosthetic Heart Valve System by Country/Region, 2020, 2024 & 2031
2.2 Percutaneous Prosthetic Heart Valve System Segment by Type
2.2.1 Balloon-expandable
2.2.2 Self-expanding
2.2.3 Other
2.3 Percutaneous Prosthetic Heart Valve System Sales by Type
2.3.1 Global Percutaneous Prosthetic Heart Valve System Sales Market Share by Type (2020-2025)
2.3.2 Global Percutaneous Prosthetic Heart Valve System Revenue and Market Share by Type (2020-2025)
2.3.3 Global Percutaneous Prosthetic Heart Valve System Sale Price by Type (2020-2025)
2.4 Percutaneous Prosthetic Heart Valve System Segment by Application
2.4.1 Hospital
2.4.2 Cardiac Catheterization Laboratory
2.4.3 Other
2.5 Percutaneous Prosthetic Heart Valve System Sales by Application
2.5.1 Global Percutaneous Prosthetic Heart Valve System Sale Market Share by Application (2020-2025)
2.5.2 Global Percutaneous Prosthetic Heart Valve System Revenue and Market Share by Application (2020-2025)
2.5.3 Global Percutaneous Prosthetic Heart Valve System Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Percutaneous Prosthetic Heart Valve System Breakdown Data by Company
3.1.1 Global Percutaneous Prosthetic Heart Valve System Annual Sales by Company (2020-2025)
3.1.2 Global Percutaneous Prosthetic Heart Valve System Sales Market Share by Company (2020-2025)
3.2 Global Percutaneous Prosthetic Heart Valve System Annual Revenue by Company (2020-2025)
3.2.1 Global Percutaneous Prosthetic Heart Valve System Revenue by Company (2020-2025)
3.2.2 Global Percutaneous Prosthetic Heart Valve System Revenue Market Share by Company (2020-2025)
3.3 Global Percutaneous Prosthetic Heart Valve System Sale Price by Company
3.4 Key Manufacturers Percutaneous Prosthetic Heart Valve System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Percutaneous Prosthetic Heart Valve System Product Location Distribution
3.4.2 Players Percutaneous Prosthetic Heart Valve System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Percutaneous Prosthetic Heart Valve System by Geographic Region
4.1 World Historic Percutaneous Prosthetic Heart Valve System Market Size by Geographic Region (2020-2025)
4.1.1 Global Percutaneous Prosthetic Heart Valve System Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Percutaneous Prosthetic Heart Valve System Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Percutaneous Prosthetic Heart Valve System Market Size by Country/Region (2020-2025)
4.2.1 Global Percutaneous Prosthetic Heart Valve System Annual Sales by Country/Region (2020-2025)
4.2.2 Global Percutaneous Prosthetic Heart Valve System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Percutaneous Prosthetic Heart Valve System Sales Growth
4.4 APAC Percutaneous Prosthetic Heart Valve System Sales Growth
4.5 Europe Percutaneous Prosthetic Heart Valve System Sales Growth
4.6 Middle East & Africa Percutaneous Prosthetic Heart Valve System Sales Growth
5 Americas
5.1 Americas Percutaneous Prosthetic Heart Valve System Sales by Country
5.1.1 Americas Percutaneous Prosthetic Heart Valve System Sales by Country (2020-2025)
5.1.2 Americas Percutaneous Prosthetic Heart Valve System Revenue by Country (2020-2025)
5.2 Americas Percutaneous Prosthetic Heart Valve System Sales by Type (2020-2025)
5.3 Americas Percutaneous Prosthetic Heart Valve System Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Percutaneous Prosthetic Heart Valve System Sales by Region
6.1.1 APAC Percutaneous Prosthetic Heart Valve System Sales by Region (2020-2025)
6.1.2 APAC Percutaneous Prosthetic Heart Valve System Revenue by Region (2020-2025)
6.2 APAC Percutaneous Prosthetic Heart Valve System Sales by Type (2020-2025)
6.3 APAC Percutaneous Prosthetic Heart Valve System Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Percutaneous Prosthetic Heart Valve System by Country
7.1.1 Europe Percutaneous Prosthetic Heart Valve System Sales by Country (2020-2025)
7.1.2 Europe Percutaneous Prosthetic Heart Valve System Revenue by Country (2020-2025)
7.2 Europe Percutaneous Prosthetic Heart Valve System Sales by Type (2020-2025)
7.3 Europe Percutaneous Prosthetic Heart Valve System Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Percutaneous Prosthetic Heart Valve System by Country
8.1.1 Middle East & Africa Percutaneous Prosthetic Heart Valve System Sales by Country (2020-2025)
8.1.2 Middle East & Africa Percutaneous Prosthetic Heart Valve System Revenue by Country (2020-2025)
8.2 Middle East & Africa Percutaneous Prosthetic Heart Valve System Sales by Type (2020-2025)
8.3 Middle East & Africa Percutaneous Prosthetic Heart Valve System Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Percutaneous Prosthetic Heart Valve System
10.3 Manufacturing Process Analysis of Percutaneous Prosthetic Heart Valve System
10.4 Industry Chain Structure of Percutaneous Prosthetic Heart Valve System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Percutaneous Prosthetic Heart Valve System Distributors
11.3 Percutaneous Prosthetic Heart Valve System Customer
12 World Forecast Review for Percutaneous Prosthetic Heart Valve System by Geographic Region
12.1 Global Percutaneous Prosthetic Heart Valve System Market Size Forecast by Region
12.1.1 Global Percutaneous Prosthetic Heart Valve System Forecast by Region (2026-2031)
12.1.2 Global Percutaneous Prosthetic Heart Valve System Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Percutaneous Prosthetic Heart Valve System Forecast by Type (2026-2031)
12.7 Global Percutaneous Prosthetic Heart Valve System Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Edwards Lifesciences
13.1.1 Edwards Lifesciences Company Information
13.1.2 Edwards Lifesciences Percutaneous Prosthetic Heart Valve System Product Portfolios and Specifications
13.1.3 Edwards Lifesciences Percutaneous Prosthetic Heart Valve System Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Edwards Lifesciences Main Business Overview
13.1.5 Edwards Lifesciences Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Percutaneous Prosthetic Heart Valve System Product Portfolios and Specifications
13.2.3 Medtronic Percutaneous Prosthetic Heart Valve System Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Boston Scientific
13.3.1 Boston Scientific Company Information
13.3.2 Boston Scientific Percutaneous Prosthetic Heart Valve System Product Portfolios and Specifications
13.3.3 Boston Scientific Percutaneous Prosthetic Heart Valve System Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boston Scientific Main Business Overview
13.3.5 Boston Scientific Latest Developments
13.4 Abbott
13.4.1 Abbott Company Information
13.4.2 Abbott Percutaneous Prosthetic Heart Valve System Product Portfolios and Specifications
13.4.3 Abbott Percutaneous Prosthetic Heart Valve System Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Abbott Main Business Overview
13.4.5 Abbott Latest Developments
13.5 MicroPort
13.5.1 MicroPort Company Information
13.5.2 MicroPort Percutaneous Prosthetic Heart Valve System Product Portfolios and Specifications
13.5.3 MicroPort Percutaneous Prosthetic Heart Valve System Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 MicroPort Main Business Overview
13.5.5 MicroPort Latest Developments
13.6 Venus Medtech
13.6.1 Venus Medtech Company Information
13.6.2 Venus Medtech Percutaneous Prosthetic Heart Valve System Product Portfolios and Specifications
13.6.3 Venus Medtech Percutaneous Prosthetic Heart Valve System Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Venus Medtech Main Business Overview
13.6.5 Venus Medtech Latest Developments
13.7 Jenscare Biotechnology
13.7.1 Jenscare Biotechnology Company Information
13.7.2 Jenscare Biotechnology Percutaneous Prosthetic Heart Valve System Product Portfolios and Specifications
13.7.3 Jenscare Biotechnology Percutaneous Prosthetic Heart Valve System Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Jenscare Biotechnology Main Business Overview
13.7.5 Jenscare Biotechnology Latest Developments
14 Research Findings and Conclusion
��
��
*If Applicable.
